NCT03721237 (EBC-PSV+Sigh) is a NA clinical trial of EBC-assisted in Respiratory Failure, sponsored by Azienda Ospedaliero Universitaria Maggiore della Carita.

Who is sponsoring NCT03721237?

NCT03721237 is sponsored by Azienda Ospedaliero Universitaria Maggiore della Carita.

What drugs are being tested in NCT03721237?

Interventions in NCT03721237: EBC-assisted.

What condition does NCT03721237 study?

NCT03721237 studies Respiratory Failure, Mechanical Ventilation Pressure High.

Is NCT03721237 still recruiting?

NCT03721237 is currently completed. Last updated 4 September 2019.

Last reviewed 2019-09-04 · How we verify

NCT03721237: EBC-PSV+Sigh

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Esophageal Balloon Calibration in Assisted Ventilation Mode

Completed NA Last updated 4 September 2019

What this trial tests

NA trial testing EBC-assisted in Respiratory Failure in 20 participants. Completed in 1 August 2019.

Timeline

15 November 2018

Primary endpoint
1 August 2019

1 August 2019

Quick facts

Lead sponsor	Azienda Ospedaliero Universitaria Maggiore della Carita
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	20
Start date	15 November 2018
Primary completion	1 August 2019
Estimated completion	1 August 2019
Sites	1 location across Italy

Drugs / interventions tested

EBC-assisted

Conditions studied

Respiratory Failure — all drugs for Respiratory Failure →
Mechanical Ventilation Pressure High — all drugs for Mechanical Ventilation Pressure High →

Sponsor

Azienda Ospedaliero Universitaria Maggiore della Carita — full company profile →

Who can join

18 and older, any sex, with Respiratory Failure or Mechanical Ventilation Pressure High. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Esophageal balloon calibration (EBC) has been proposed during controlled mechanical ventilation in intubated patients in order to optimize esophageal pressure (Pes) signal. Actually, at our knowledge, no data exist about EBC during assisted ventilatory modes such as Pressure Support Ventilation (PSV). The primary endpoint of the present investigation is to assess the feasibility of EBC during PSV and PSV plus Sigh.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiratory Failure

Currently open trials in the same condition.

NCT07522450 — Benefit of Sleep Quality Monitoring by EEG in ICU · recruiting
NCT07359261 — Transpulmonary Assessment for Individualized Lung Optimization in Obese Patients · Phase 2 · recruiting
NCT07536750 — Comparison of the Efficacy and Safety of Ciprofol Versus Propofol for Sedation in ICU Patients Undergoing Non-Invasive V · recruiting
NCT07114289 — Spontaneous Breathing Trials Using Pressure Support or T-Piece in Overweight and Obese Patients · NA · recruiting
NCT06591533 — The Effect of Music Therapy on Vital Signs and Heart Rate Variability of Pediatric Patients During the Extubation Proces · NA · recruiting

Other Azienda Ospedaliero Universitaria Maggiore della Carita trials

Trials by the same sponsor.

NCT06542926 — NON-COlorectal Liver METastases Undergoing Liver Resection · not yet recruiting
NCT05298891 — Hypoproteic Diet in Acromegaly · NA · unknown
NCT06438900 — Investigating the Link Between Advanced Glycation End Products (AGEs) and Muscle Wasting in Sarcobesity · recruiting
NCT06370507 — Monitoring of Lung Ventilation Through Electrical Impedance Tomography During Pediatric Surgery · not yet recruiting
NCT06312280 — Evaluation of Body Composition in Pediatric Patients With Overweight or Obesity · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03721237 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero Universitaria Maggiore della Carita
Last refreshed: 4 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03721237.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing